SAiGENCI researcher granted national health funding
SAiGENCI research into using PROTACs for cancer treatments has been funded in the latest round of the National Health and Medical Research Council (NHMRC) Investigator Grants.
Dr Fuyi Li
is one of five University of 新浪彩票 investigators sharing in more than $8.4 million toward health research.
Professor Anton Middelberg, Deputy Vice-Chancellor (Research), University of 新浪彩票, congratulated the recipients.
鈥淭he University of 新浪彩票 is committed to creating a way to improve the health and wellbeing of society and these NHMRC grants are the latest example of this,鈥 said Professor Middelberg.
Dr Li is Group Leader of the Artificial Intelligence for Biological Innovation (ABI Lab) within SAiGENCI's Computational Systems Oncology 辫谤辞驳谤补尘.听 He has been granted $688,405 to advance his research into using Proteolysis Targeting Chimera (PROTACs) for cancer treatments.
PROTACs are small molecules that break down specific proteins in cells, which Dr Li will create using advanced artificial intelligence techniques, making them more effective and faster to produce.